Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Discovery of Di- and Trihaloacetamides as Covalent SARS-CoV-2 Main Protease Inhibitors with High Target Specificity.
J Am Chem Soc. 2021 Dec 15;143(49):20697-20709. doi: 10.1021/jacs.1c08060. Epub 2021 Dec 3.
J Am Chem Soc. 2021.
PMID: 34860011
Free PMC article.
Validation and invalidation of SARS-CoV-2 main protease inhibitors using the Flip-GFP and Protease-Glo luciferase assays.
Ma C, Tan H, Choza J, Wang Y, Wang J.
Ma C, et al. Among authors: choza j.
Acta Pharm Sin B. 2022 Apr;12(4):1636-1651. doi: 10.1016/j.apsb.2021.10.026. Epub 2021 Nov 1.
Acta Pharm Sin B. 2022.
PMID: 34745850
Free PMC article.
Item in Clipboard
Drug-Repurposing Screening Identified Tropifexor as a SARS-CoV-2 Papain-like Protease Inhibitor.
Ma C, Hu Y, Wang Y, Choza J, Wang J.
Ma C, et al. Among authors: choza j.
ACS Infect Dis. 2022 May 13;8(5):1022-1030. doi: 10.1021/acsinfecdis.1c00629. Epub 2022 Apr 11.
ACS Infect Dis. 2022.
PMID: 35404564
Free PMC article.
Item in Clipboard
Cite
Cite